{
  "id": "cluster_13_docid3",
  "content": "Provider report from Dr. Elise Tan (ID 45TX982) outlines treatment complications for patient Lila Voss. Concurrent actemra infusions and lupus study participation caused elevated hepatic enzymes (ALT 78 U/L). Recommended protocol adjustments: reduce infusion frequency to 3-week intervals and add monthly liver function panels through Desert Valley Labs.",
  "metadata": {
    "format": "provider_report"
  }
}